Powered Echelon Device in VATS Surgery

Inclusion Criteria: * Histologically confirmed NSCLC (up to and including Stage II) for patients undergoing VATS lobectomy. For patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from CRC, a malignant diagnosis may be confirmed post-operatively. * Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung * Willing to give consent and comply with evaluation and treatment schedule * At least 18 years of age Exclusion Criteria: * Active bacterial infection or fungal infection * Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure) * Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure * Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed); * Prior history of VATS or open lung surgery